SNY Related Guidance
-
Genzyme (GENZ) Confirms Issues Discussed in Presentation This Morning: $89/Share Estimate, Q4, FY11 Outlook
-
Highlights From AAPL's Q4 Conference Call: Set New All-Time Records for Mac, iPhone and iPad Sales
-
Sanofi-Aventis (SNY) Cuts Outlook Amid Generic Lovenox Approval; Analysts Mixed
-
Exelixis (EXEL) Tops Q3 EPS by 8c; Comments on Outlook
-
Bristol-Myers Squibb (BMY) Lowers FY EPS Guidance on Generic PLAVIX Already on Market
-
sanofi-aventis (SNY) Cuts 2006 EPS Growth Target On Already Shipped Generic Plavix
Back to SNY Stock Lookup
